These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38384303)

  • 1. Leveraging baseline transcriptional features and information from single-cell data to power the prediction of influenza vaccine response.
    Ye X; Yang S; Tu J; Xu L; Wang Y; Chen H; Yu R; Huang P
    Front Cell Infect Microbiol; 2024; 14():1243586. PubMed ID: 38384303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation.
    Quach HQ; Goergen KM; Grill DE; Haralambieva IH; Ovsyannikova IG; Poland GA; Kennedy RB
    Front Immunol; 2023; 14():1168784. PubMed ID: 37600811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes.
    Forst CV; Chung M; Hockman M; Lashua L; Adney E; Hickey A; Carlock M; Ross T; Ghedin E; Gresham D
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response.
    Tan Y; Tamayo P; Nakaya H; Pulendran B; Mesirov JP; Haining WN
    Eur J Immunol; 2014 Jan; 44(1):285-95. PubMed ID: 24136404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant Antibody Repertoires during the First Two Years of Influenza Vaccination.
    Kuraoka M; Curtis NC; Watanabe A; Tanno H; Shin S; Ye K; Macdonald E; Lavidor O; Kong S; Von Holle T; Windsor I; Ippolito GC; Georgiou G; Walter EB; Kelsoe G; Harrison SC; Moody MA; Bajic G; Lee J
    mBio; 2022 Dec; 13(6):e0254622. PubMed ID: 36314798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
    ; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
    Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children.
    de Armas LR; George V; Filali-Mouhim A; Steel C; Parmigiani A; Cunningham CK; Weinberg A; Trautmann L; Sekaly RP; Cameron MJ; Pahwa S
    Front Immunol; 2021; 12():639358. PubMed ID: 33868267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection.
    Kim YH; Bang YJ; Park HJ; Li Ko H; Park SI; Hwang KA; Kim H; Nam JH
    Vaccine; 2020 Sep; 38(39):6141-6152. PubMed ID: 32739118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.
    Avey S; Mohanty S; Chawla DG; Meng H; Bandaranayake T; Ueda I; Zapata HJ; Park K; Blevins TP; Tsang S; Belshe RB; Kaech SM; Shaw AC; Kleinstein SH
    J Immunol; 2020 Mar; 204(6):1661-1673. PubMed ID: 32060136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence Applied to
    Cotugno N; Santilli V; Pascucci GR; Manno EC; De Armas L; Pallikkuth S; Deodati A; Amodio D; Zangari P; Zicari S; Ruggiero A; Fortin M; Bromley C; Pahwa R; Rossi P; Pahwa S; Palma P
    Front Immunol; 2020; 11():559590. PubMed ID: 33123133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice.
    Beukema M; Gong S; Al-Jaawni K; de Vries-Idema JJ; Krammer F; Zhou F; Cox RJ; Huckriede A
    Front Immunol; 2023; 14():1249902. PubMed ID: 37869002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination features revealed by a single-cell transcriptome atlas.
    Wang Y; Wang X; Jia X; Li J; Fu J; Huang X; Cui X; Wang B; Luo W; Lin C; Li Z; Luu LDW; Li S; Zhu X; Tai J
    J Med Virol; 2023 Jan; 95(1):e28174. PubMed ID: 36163452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination.
    Jürchott K; Schulz AR; Bozzetti C; Pohlmann D; Stervbo U; Warth S; Mälzer JN; Waldner J; Schweiger B; Olek S; Grützkau A; Babel N; Thiel A; Neumann AU
    PLoS One; 2016; 11(3):e0150812. PubMed ID: 26954292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine.
    Alcorn JF; Avula R; Chakka AB; Schwarzmann WE; Nowalk MP; Lin CJ; Ortiz MA; Horne WT; Chandran UR; Nagg JP; Zimmerman RK; Cole KS; Moehling KK; Martin JM
    Hum Vaccin Immunother; 2020 Aug; 16(8):1782-1790. PubMed ID: 32298194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    Price GE; Lo CY; Misplon JA; Epstein SL
    J Virol; 2022 Jun; 96(12):e0032022. PubMed ID: 35638848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.
    Andrews SF; Kaur K; Pauli NT; Huang M; Huang Y; Wilson PC
    J Virol; 2015 Mar; 89(6):3308-17. PubMed ID: 25589639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.